Cargando…

Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles

AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive co...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rutian, Wu, Wei, Liu, Qin, Wu, Puyuan, Xie, Li, Zhu, Zhenshu, Yang, Mi, Qian, Xiaoping, Ding, Yin, Yu, Lixia, Jiang, Xiqun, Guan, Wenxian, Liu, Baorui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728361/
https://www.ncbi.nlm.nih.gov/pubmed/23936062
http://dx.doi.org/10.1371/journal.pone.0069643
_version_ 1782278850375319552
author Li, Rutian
Wu, Wei
Liu, Qin
Wu, Puyuan
Xie, Li
Zhu, Zhenshu
Yang, Mi
Qian, Xiaoping
Ding, Yin
Yu, Lixia
Jiang, Xiqun
Guan, Wenxian
Liu, Baorui
author_facet Li, Rutian
Wu, Wei
Liu, Qin
Wu, Puyuan
Xie, Li
Zhu, Zhenshu
Yang, Mi
Qian, Xiaoping
Ding, Yin
Yu, Lixia
Jiang, Xiqun
Guan, Wenxian
Liu, Baorui
author_sort Li, Rutian
collection PubMed
description AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive copolymer (mPEG-PCL) by inserting a gelatinase cleavable peptide (PVGLIG) between mPEG and PCL blocks of mPEG-PCL for anticancer drug delivery to make use of MMP2/9 as an intelligent target for drug delivery. MATERIALS AND METHODS: mPEG-pep-PCL copolymer was synthesized via ring-opening copolymerization and double-amidation. To evaluate whether Nanoparticles (NPs) prepared from this copolymer are superior to NPs prepared from mPEG-PCL, NPs prepared from mPEG-PCL copolymer were used as positive control. Docetaxel-loading NPs using mPEG-pep-PCL and mPEG-PCL were prepared by nano-precipitation method, mentioned as Gel-NPs and Con-NPs, respectively. The morphologic changes of the NPs after treatment with gelatinases were observed macroscopically by spectrophotometer and microscopically by transmission electron microscopy (TEM) and atomic force microscopy (AFM). The cellular uptake amount and cytotoxicity of Gel-NPs and Con-NPs, respectively, in cell lines with different levels of gelatinase expression were studied. Moreover, the cytotoxicity study on the primary cancer cells isolated from pericardial fluids from a patient with late-stage lung cancer was conducted. RESULTS: The Gel-NPs aggregated in response to gelatinases, which was confirmed macroscopically and microscopically. The cellular uptake amount of Gel-NPs was correlated with the level of gelatinases. The in vitro antitumor effect of Gel-NPs was also correlated with the level of gelatinases and was superior to Taxotere (commercially available docetaxel) as well as the Con-NPs. The cytotoxicity study on the primary lung cancer cells also confirmed the effectiveness of Gel-NPs. CONCLUSION: The results in this study preliminarily demonstrated the effectiveness of gelatinase-responsive targeting strategy and the prospect of this intelligent nano-drug delivery system though further studies are needed.
format Online
Article
Text
id pubmed-3728361
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37283612013-08-09 Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles Li, Rutian Wu, Wei Liu, Qin Wu, Puyuan Xie, Li Zhu, Zhenshu Yang, Mi Qian, Xiaoping Ding, Yin Yu, Lixia Jiang, Xiqun Guan, Wenxian Liu, Baorui PLoS One Research Article AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive copolymer (mPEG-PCL) by inserting a gelatinase cleavable peptide (PVGLIG) between mPEG and PCL blocks of mPEG-PCL for anticancer drug delivery to make use of MMP2/9 as an intelligent target for drug delivery. MATERIALS AND METHODS: mPEG-pep-PCL copolymer was synthesized via ring-opening copolymerization and double-amidation. To evaluate whether Nanoparticles (NPs) prepared from this copolymer are superior to NPs prepared from mPEG-PCL, NPs prepared from mPEG-PCL copolymer were used as positive control. Docetaxel-loading NPs using mPEG-pep-PCL and mPEG-PCL were prepared by nano-precipitation method, mentioned as Gel-NPs and Con-NPs, respectively. The morphologic changes of the NPs after treatment with gelatinases were observed macroscopically by spectrophotometer and microscopically by transmission electron microscopy (TEM) and atomic force microscopy (AFM). The cellular uptake amount and cytotoxicity of Gel-NPs and Con-NPs, respectively, in cell lines with different levels of gelatinase expression were studied. Moreover, the cytotoxicity study on the primary cancer cells isolated from pericardial fluids from a patient with late-stage lung cancer was conducted. RESULTS: The Gel-NPs aggregated in response to gelatinases, which was confirmed macroscopically and microscopically. The cellular uptake amount of Gel-NPs was correlated with the level of gelatinases. The in vitro antitumor effect of Gel-NPs was also correlated with the level of gelatinases and was superior to Taxotere (commercially available docetaxel) as well as the Con-NPs. The cytotoxicity study on the primary lung cancer cells also confirmed the effectiveness of Gel-NPs. CONCLUSION: The results in this study preliminarily demonstrated the effectiveness of gelatinase-responsive targeting strategy and the prospect of this intelligent nano-drug delivery system though further studies are needed. Public Library of Science 2013-07-30 /pmc/articles/PMC3728361/ /pubmed/23936062 http://dx.doi.org/10.1371/journal.pone.0069643 Text en © 2013 Li et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Li, Rutian
Wu, Wei
Liu, Qin
Wu, Puyuan
Xie, Li
Zhu, Zhenshu
Yang, Mi
Qian, Xiaoping
Ding, Yin
Yu, Lixia
Jiang, Xiqun
Guan, Wenxian
Liu, Baorui
Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
title Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
title_full Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
title_fullStr Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
title_full_unstemmed Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
title_short Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
title_sort intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728361/
https://www.ncbi.nlm.nih.gov/pubmed/23936062
http://dx.doi.org/10.1371/journal.pone.0069643
work_keys_str_mv AT lirutian intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT wuwei intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT liuqin intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT wupuyuan intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT xieli intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT zhuzhenshu intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT yangmi intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT qianxiaoping intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT dingyin intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT yulixia intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT jiangxiqun intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT guanwenxian intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles
AT liubaorui intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles